Excellerate Bioscience Excellerate Bioscience
  • Home
  • About Us
    • About Us
    • Company History
    • Meet the Team
    • How We Work
  • Capabilities
    • Supporting Drug Discovery
    • Targets and Therapeutic Areas
    • Cellular Pharmacology
    • Screening Services
    • Assay Development
    • Mechanism of Action
  • News & Events
  • Resources
  • Careers
CONTACT US

Excellerate Bioscience News

Excellerate Bioscience in successful EU consortium bid to develop new obesity therapeutics

February 8, 2021
excellbio2020 2021-02-08T12:47:44+00:00
Excellerate Bioscience News

Excellerate Bioscience client AdoRx announces strategic partnership with Johnson & Johnson

October 26, 2020
excellbio2020 2020-10-26T11:20:54+00:00
Excellerate Bioscience News

AdAlta and Excellerate Bioscience collaborate to advance the development of i-body pipeline

October 26, 2020
excellbio2020 2020-10-26T11:19:08+00:00
Excellerate Bioscience News

Cisbio and Excellerate Bioscience partner on ligand kinetic binding services

October 26, 2020
excellbio2020 2020-10-26T11:17:32+00:00
Excellerate Bioscience News

Leigh Stoddart joins the team as Associate Principal Scientist

February 12, 2021
excellbio2020 2021-02-12T09:46:59+00:00
Contact Us

BioCity
Pennyfoot Street
Nottingham
NG1 1GF
+44 (0) 115 8248243
info@excelleratebio.com

Company Registration No. 10228159
Vat No. GB 248960957

Please send me latest news and updates from Excellerate Bioscience


© 2021 Excellerate Bioscience

  • Privacy Policy
  • Home
  • About Us
    • About Us
    • Company History
    • Meet the Team
    • How We Work
  • Capabilities
    • Supporting Drug Discovery
    • Targets and Therapeutic Areas
    • Cellular Pharmacology
    • Screening Services
    • Assay Development
    • Mechanism of Action
  • News & Events
  • Resources
  • Careers